Bloomberg Businessweek Weekend - April 28th, 2023
Bloomberg Businessweek
00:00
The Risks of Obesity
There's a big kind of murky middle of people where it's not totally clear how big a danger than they're weight poses. So if you think about it, maybe not everyone who qualifies as overweight or obese is necessarily going to be the best candidate for these drugs. There have been studies of this new drug, Guagovi, that show when people quit the drug after a year, the weight comes back for most people.
Play episode from 01:13:35
Transcript
